"Tag Team" Glioblastoma Therapy: Results From a Phase 1 Trial of Toca 511 and 5-Fluorocytosine for Recurrent High-Grade Glioma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurosurgery

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1227/01.NEU.0000508605.38694.FDPMID 27861411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

  2016cited by this paper

• The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma

  2024cites this paper
• Cell and gene therapies—Emerging technologies and drug delivery systems for treating brain cancer

  2021cites this paper
• Glioblastoma treatment guidelines: Consensus by the Spanish Society of Neurosurgery Tumor Section.

  2020cites this paper
• Comprehensive mutagenesis on yeast cytosine deaminase yields improvements in 5‐fluorocytosine toxicity in HT1080 cells

  2020cites this paper
• Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme

  2020cites this paper
• Glioblastoma treatment guidelines: Consensus by the Spanish Society of Neurosurgery Tumor Section

  2020cites this paper
• Immunotherapy and Gliomas

  2019cites this paper
• Jinlong capsule inhibits migration and invasion in human glioblastoma cells via the modulation of mTOR/S6 signaling pathway

  2019cites this paper
• Jinlong capsule inhibits migration and invasion in human glioblastoma cells via the modulation of mTOR/S6 signaling pathway

  2019cites this paper
• Jinlong capsule inhibits migration and invasion in human glioblastoma cells via the modulation of mTOR/S6 signaling pathway

  2019cites this paper
• Paclitaxel Enhances Oncolytic Potential of Herpes Simplex Virus Type-1 in Cancer Cells

  2018cites this paper
• Biomarkers and therapeutic advances in glioblastoma multiforme

  2018cites this paper
• From Foe to Friend: Therapeutic and Commercial Applications of Engineered Viruses

  2018cites this paper
• Glioblastoma Treatments: An Account of Recent Industrial Developments

  2018cites this paper